ILIAS
LIVE

Serial Number

88776160

Owner

ILIAS Biologics Inc.

Attorney

Janice Housey

Filing Date

Jan 28, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ILIAS Trademark

Serial Number: 88776160 • Registration: 6920489

ILIAS is a trademark filed by ILIAS Biologics Inc. on January 28, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

ILIAS Biologics Inc. (11 trademarks)

40-20 Techno 6-ro, Yuseong-gu
Daejeon 34014 , KR

Entity Type: 03

Trademark Details

Filing Date

January 28, 2020

Registration Date

December 13, 2022

Published for Opposition

September 27, 2022

Goods & Services

Electric bio-sensors; glassware for laboratory scientific experiments; incubator for laboratory use in cell culture; laboratory equipment, namley, protein sequence analysis equipment being laboratory apparatus; nucleic acid sequencers for scientific purposes for use in analyzing nucleic acide; petri dishes for laboratory use used in cell culture; bioreactor for cell culturing; apparatus for analyzing biochips for laboratory use; laboratory centrifuges; cell culture apparatus for laboratory use, namely, bioreactor for cell culturing; probes for scientific purposes; physical and chemical laboratory apparatus and instruments, namley, apparatus and instruments for cell culturing; particle foreign substances detectors for laboratory use, namely, detectors used in cell culturing; ultrasonic sensors for molecular biology research in the nature of sensors used in cell culturing; bioreactors for laboratory use; microscopes for medical use; laboratory chemical reactors

Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale store services featuring drugs; retail and wholesale store services featuring veterinary drugs; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring health preparations; retail and wholesale store services featuring medical supplies; retail and wholesale store services featuring preparations for veterinary use; sales promotion for others; marketing services

Biochemicial drug for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; diagnostic reagents for medical purposes; pharmaceutical preparations for treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; stem cells for veterinary purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; enzyme preparations for medical purposes; chemical preparations for medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; diagnostic preparations for medical purposes; chemico-pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical reagents for medical or veterinary purposes; preparations of microorganisms for medical and veterinary use for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; genetic identity tests comprised of reagents for medical purposes; biological preparations for medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological preparations for veterinary purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; bacteriological preparations for medical and veterinary use; biological reagents for clinical medical use; stem cells for medical purposes; drugs for medical purposes featuring drugs for the purpose of treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; medicines for human purposes featuring medicines for the purpose of treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; pharmaceutical preparations for the treatment of immune system related diseases and disorders; cell therapeutics for medical use

Diagnostic reagents and preparations, other than for medical or veterinary use; biologics in the nature of biological preparations for use in cell cultures, other than for medical or veterinary use; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemical catalysts; biological preparations for use in industry and science, other than for medical or veterinary purposes; bacterial preparations other than for medical and veterinary use; bacteriological preparations other than for medical and veterinary use; cultures of microorganisms, other than for medical and veterinary use; industrial chemicals; diagnostic preparations, other than for medical or veterinary purposes; biological tissue cultures other than for medical or veterinary purposes; preparations of microorganisms, other than for medical and veterinary use; adjuvants, other than for medical or veterinary purposes; reagent paper, other than for medical or veterinary purposes; stem cells other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes

Research and development of technology for biotechnology in the nature of cell biology; biomedical research services; technological research in the field of cell biology; scientific research; biological research; laboratory research in the field of cell biology; scientific research and development; biological research and analysis; biotechnological research; cell separation research services; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; medical research; laboratory research in the field of pharmaceuticals; genetic testing for scientific research purposes; structural and functional analysis of genomes; medical laboratory services; stem cell research services; scientific laboratory services

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 16, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 16, 2026 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Mar 16, 2026 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 16, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 16, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 16, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 16, 2026 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 13, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 27, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 27, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 7, 2022 NONP
1(B) BASIS DELETED; NEW BASIS REQUESTED
Aug 23, 2022 ADBS
NOTICE OF ALLOWANCE CANCELLED
Aug 23, 2022 IUCN
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Aug 23, 2022 PCBG
ASSIGNED TO PETITION STAFF
Aug 22, 2022 APET
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 18, 2022 EXRA
SOU EXTENSION 3 GRANTED
Aug 16, 2022 EX3G
SOU EXTENSION 3 FILED
Aug 16, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 16, 2022 EEXT
TEAS PETITION TO AMEND BASIS RECEIVED
Jul 27, 2022 TPAD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 18, 2022 EXRA
SOU EXTENSION 2 GRANTED
Feb 16, 2022 EX2G
SOU EXTENSION 2 FILED
Feb 16, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 16, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 18, 2021 EXRA
SOU EXTENSION 1 GRANTED
Aug 16, 2021 EX1G
SOU EXTENSION 1 FILED
Aug 16, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 16, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 16, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 22, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 22, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 2, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 18, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 18, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 18, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 18, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 18, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 27, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 27, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 27, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 27, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 27, 2020 GNRT
NON-FINAL ACTION WRITTEN
Apr 27, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 16, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2020 NWOS
NEW APPLICATION ENTERED
Jan 31, 2020 NWAP